primary dysmenorrhea.
Conditions
Interventions
Intervention 1: Intervention group:received willow bark extract capsule (240 mg salicin ) with Placebo three times daily, produced by Medical Plants Research Center, Basic Health Sciences Institute,
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 28 Years
Inclusion criteria
Inclusion criteria: suffering from level two or three primary dysmenorrhea according to the Andersch and Milsom’s verbal multi-dimensional scoring system aged 18 to 28 years old regular menstrual cycles without history of allergy to willow bark single students
Exclusion criteria
Exclusion criteria: absence of any genital organs diseases history of hypersensitivity to NSAIDs systemic diseases neurologic or psychiatric disease surgery during the past eight weeks hormonal therapy during the last six months used contraceptives
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain level. Timepoint: Before intervention and After Intervention. Method of measurement: visual analog scale (VAS).;Menstrual symptoms. Timepoint: Before intervention and After Intervention. Method of measurement: COX menstrual symptom scale.;Bleeding amount. Timepoint: Before intervention and After Intervention. Method of measurement: Pictorial blood assessment chart. | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety and adverse event. Timepoint: After intervention. Method of measurement: case-report form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZiba Raisi Dehkordi
Shahre-kord University of Medical Sciences
Outcome results
None listed